The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
Brief Report
PreviousPrevious
Volume 338:1585-1590 May 28, 1998 Number 22
NextNext

Transient Angiolymphoid Hyperplasia and Kaposi's Sarcoma after Primary Infection with Human Herpesvirus 8 in a Patient with Human Immunodeficiency Virus Infection
Eric Oksenhendler, M.D., Dominique Cazals-Hatem, M.D., Thomas F. Schulz, M.D., Véronique Barateau, B.Sc., Laurence Grollet, B.Sc., Julie Sheldon, B.Sc., Jean-Pierre Clauvel, M.D., François Sigaux, M.D., Ph.D., and Félix Agbalika, M.D.

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
DNA sequences of human herpesvirus 8 (HHV-8) have been detected in all forms of Kaposi's sarcoma.1,2,3 HHV-8 has also been detected in primary effusion lymphomas,4 Castleman's disease,5 and multiple myeloma6 and reported anecdotally in cases of angioimmunoblastic lymphadenopathy and germinal-center hyperplasia.7 Indirect immunofluorescence and immunoblot assays, based on antigens from a latently infected lymphoma cell line, have shown that HHV-8 is not a ubiquitous viral infection in humans. The overall seroprevalence of HHV-8 is less than 5 percent in the United States and United Kingdom, up to 35 percent in southern Italy, and over 50 percent in East Africa.8,9,10,11,12,13 Seroconversion . . . [Full Text of this Article]

Case Report

Methods

Histopathological, Immunohistochemical, and in Situ Hybridization Studies

Amplification and Southern Blotting

Serologic Tests for HHV-8

Results

Discussion


Source Information

From the Departments of Immunology and Hematology (E.O., J.-P.C.) and Pathology (D.C.-H.) and the Laboratories of Virology (V.B., F.A.) and Molecular Hematology (L.G., F.S.), Hôpital Saint-Louis, Paris; and the Department of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool, United Kingdom (T.F.S., J.S.).

Address reprint requests to Dr. Oksenhendler at the Service d'Immuno-Hématologie, Hôpital Saint-Louis, 1 Ave. Claude Vellefaux, 75010 Paris, France.

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.